Cargando…
Pulmonary arterial hypertension due to antiphospholipid syndrome initially mimicking chronic thromboembolic pulmonary hypertension
Pulmonary arterial hypertension (PAH) is the second most common lung complication in antiphospholipid syndrome (APS) patients. However, the concurrent development of APS-related nonthrombotic PAH is rarely reported. Lack of awareness for group 1 PAH in APS patient may contribute to underdiagnosis of...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8973988/ https://www.ncbi.nlm.nih.gov/pubmed/35361265 http://dx.doi.org/10.1186/s40885-021-00191-1 |
_version_ | 1784680163820175360 |
---|---|
author | Yeo, Jina Shin, Nami Ahn, Kyung-Jin Seo, Miryoung Jang, Albert Youngwoo Kim, Minsu Chung, Wook-Jin |
author_facet | Yeo, Jina Shin, Nami Ahn, Kyung-Jin Seo, Miryoung Jang, Albert Youngwoo Kim, Minsu Chung, Wook-Jin |
author_sort | Yeo, Jina |
collection | PubMed |
description | Pulmonary arterial hypertension (PAH) is the second most common lung complication in antiphospholipid syndrome (APS) patients. However, the concurrent development of APS-related nonthrombotic PAH is rarely reported. Lack of awareness for group 1 PAH in APS patient may contribute to underdiagnosis of this condition. Herein, we reviewed the case of a 56-year-old female who was diagnosed with PAH related to APS that mimicked chronic thromboembolic pulmonary hypertension (CTEPH). It is crucial to be aware of the possibility of a group 1 PAH diagnosis, even though patients have already been diagnosed with CTEPH. Furthermore, a multidisciplinary approach and serial follow-up right heart catheterization with echocardiography are important to make a timely diagnosis and provide optimal treatment for APS-related PAH in patients with CTEPH-like clinical features. |
format | Online Article Text |
id | pubmed-8973988 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-89739882022-04-02 Pulmonary arterial hypertension due to antiphospholipid syndrome initially mimicking chronic thromboembolic pulmonary hypertension Yeo, Jina Shin, Nami Ahn, Kyung-Jin Seo, Miryoung Jang, Albert Youngwoo Kim, Minsu Chung, Wook-Jin Clin Hypertens Letter to the Editor Pulmonary arterial hypertension (PAH) is the second most common lung complication in antiphospholipid syndrome (APS) patients. However, the concurrent development of APS-related nonthrombotic PAH is rarely reported. Lack of awareness for group 1 PAH in APS patient may contribute to underdiagnosis of this condition. Herein, we reviewed the case of a 56-year-old female who was diagnosed with PAH related to APS that mimicked chronic thromboembolic pulmonary hypertension (CTEPH). It is crucial to be aware of the possibility of a group 1 PAH diagnosis, even though patients have already been diagnosed with CTEPH. Furthermore, a multidisciplinary approach and serial follow-up right heart catheterization with echocardiography are important to make a timely diagnosis and provide optimal treatment for APS-related PAH in patients with CTEPH-like clinical features. BioMed Central 2022-04-01 /pmc/articles/PMC8973988/ /pubmed/35361265 http://dx.doi.org/10.1186/s40885-021-00191-1 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Letter to the Editor Yeo, Jina Shin, Nami Ahn, Kyung-Jin Seo, Miryoung Jang, Albert Youngwoo Kim, Minsu Chung, Wook-Jin Pulmonary arterial hypertension due to antiphospholipid syndrome initially mimicking chronic thromboembolic pulmonary hypertension |
title | Pulmonary arterial hypertension due to antiphospholipid syndrome initially mimicking chronic thromboembolic pulmonary hypertension |
title_full | Pulmonary arterial hypertension due to antiphospholipid syndrome initially mimicking chronic thromboembolic pulmonary hypertension |
title_fullStr | Pulmonary arterial hypertension due to antiphospholipid syndrome initially mimicking chronic thromboembolic pulmonary hypertension |
title_full_unstemmed | Pulmonary arterial hypertension due to antiphospholipid syndrome initially mimicking chronic thromboembolic pulmonary hypertension |
title_short | Pulmonary arterial hypertension due to antiphospholipid syndrome initially mimicking chronic thromboembolic pulmonary hypertension |
title_sort | pulmonary arterial hypertension due to antiphospholipid syndrome initially mimicking chronic thromboembolic pulmonary hypertension |
topic | Letter to the Editor |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8973988/ https://www.ncbi.nlm.nih.gov/pubmed/35361265 http://dx.doi.org/10.1186/s40885-021-00191-1 |
work_keys_str_mv | AT yeojina pulmonaryarterialhypertensionduetoantiphospholipidsyndromeinitiallymimickingchronicthromboembolicpulmonaryhypertension AT shinnami pulmonaryarterialhypertensionduetoantiphospholipidsyndromeinitiallymimickingchronicthromboembolicpulmonaryhypertension AT ahnkyungjin pulmonaryarterialhypertensionduetoantiphospholipidsyndromeinitiallymimickingchronicthromboembolicpulmonaryhypertension AT seomiryoung pulmonaryarterialhypertensionduetoantiphospholipidsyndromeinitiallymimickingchronicthromboembolicpulmonaryhypertension AT jangalbertyoungwoo pulmonaryarterialhypertensionduetoantiphospholipidsyndromeinitiallymimickingchronicthromboembolicpulmonaryhypertension AT kimminsu pulmonaryarterialhypertensionduetoantiphospholipidsyndromeinitiallymimickingchronicthromboembolicpulmonaryhypertension AT chungwookjin pulmonaryarterialhypertensionduetoantiphospholipidsyndromeinitiallymimickingchronicthromboembolicpulmonaryhypertension |